Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

100186

	registered interest
	date	21/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patients: Safety
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether missed or inadequate hydrocortisone administration is included in the NHS list of Never Events.
	tabling member constituency	Oxford East
	tabling member printed	Mr Andrew Smith
	uin	211233
	answer	answer is ministerial correction date of answer 28/10/2014 answer text <p>Missed or inadequate hydrocortisone administration is not currently included in the list of ‘never events’.</p><p> </p><p> </p><p> </p><p>We can confirm that the current list of Never Events is under review and there is a consultation underway which opened online on the 6 October 2014 and closes on 31 October 2014.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 28/10/2014 15:28:25 question first ministerially corrected 28/10/2014 16:30:53 answering member 4020 label Biography information for George Freeman previous answer version 24770 answering member constituency Battersea answering member printed Jane Ellison answering member 3918
	tabling member	95 label Biography information for Mr Andrew Smith

100157

	registered interest
	date	21/10/2014
	answering body	Department for Energy and Climate Change
	answering dept id	63
	answering dept short name	Energy and Climate Change
	answering dept sort name	Energy and Climate Change
	hansard heading	Energy: Prices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Energy and Climate Change, what estimate he has made of the likely total allocation from the levy control framework for (a) feed in tariffs, (b) renewables obligations and (c) projects agreed under the final investment decision-enabling process in each year from 2015 to 2021.
	tabling member constituency	Rutherglen and Hamilton West
	tabling member printed	Tom Greatrex
	uin	211400
	answer	answer is ministerial correction date of answer 24/10/2014 answer text <p>The projected allocation from the levy control framework for feed in tariffs, the renewables obligation and projects agreed under the final investment decision-enabling process in financial years from 2015/16 to 2020/21 <del class="ministerial">will be</del> <ins class="ministerial">is expected to be</ins> published in an annex (‘DECC’s Consumer Funded Policies – a report to Parliament’) to the Annual Energy Statement.</p><p>Publication of the Annual Energy Statement is expected in Autumn 2014.</p><p> </p><p> </p><p> </p> answering member constituency West Suffolk answering member printed Matthew Hancock question first answered 24/10/2014 13:35:38 question first ministerially corrected 28/10/2014 16:37:54 answering member 4070 label Biography information for Matt Hancock previous answer version 24144 answering member constituency West Suffolk answering member printed Matthew Hancock answering member 4070 label Biography information for Matt Hancock
	tabling member	4047 label Biography information for Tom Greatrex

101492

	registered interest
	date	28/10/2014
	answering body	Ministry of Justice
	answering dept id	54
	answering dept short name	Justice
	answering dept sort name	Justice
	hansard heading	Prisons: Locks and Keys
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Justice, how many incidents of lost keys have required the relocking of prisons since May 2010; and at what cost.
	tabling member constituency	Tooting
	tabling member printed	Sadiq Khan
	uin	212348
	answer	answer is ministerial correction date of answer 03/11/2014 answer text <p>Security is paramount within prisons and it is important that the risk of any potential key compromise is addressed as quickly as possible in order to protect the public. When a key/lock incident is reported an immediate investigation is undertaken to assess the risk and unless it is clear that security has not been compromised, then locking mechanisms and keys will be replaced and/or other necessary remedial action will be taken.</p><p> </p><p>A range of procedural and physical measures are used to assist in the secure management of keys in prisons. These increasingly include electronic and biometric systems.</p><p> </p><p>The information requested is provided below.</p><p> </p><p>Table 1 - costs of partial/full relocking of prisons due to loss of keys from May 2010 - 29 October 2014:</p><p> </p><p>14/05/2010 Swaleside £95,430</p><p>21/06/2010 Glen Parva £208,329</p><p>04/11/2010 Warren Hill £101,301</p><p>20/12/2010 Ashwell £15,576</p><p>24/10/2011 Birmingham £499,000 <ins class="ministerial">(Paid for by G4S)</ins></p><p>09/01/2012 Maidstone £5,847</p><p>28/02/2014 Lindholme £40,286</p><p>08/05/2014 Haverigg £32,882</p><p>21/07/2014 Highpoint £14, 933</p><p> </p><p>Table 2 – number of reported incidents of lost keys from April 2010 – 31 March 2014:</p><p> </p><p>2010/11 - 62</p><p>2011/12 - 67</p><p>2012/13 – 73</p><p>2013/14 – 35 (* see note below)</p><p> </p><p>* Note: a change in the reporting requirements for key/lock incidents from April 2013 has resulted in a lower “lost keys” figure for 2013/14 in comparison to the three previous years. In addition to keys “lost”, the figures for the three previous years include keys inadvertently taken out of prisons and subsequently returned, but the figure for 2013/14 includes only keys lost, not those inadvertently taken out and returned.</p><p> </p><p><em>The figures quoted have been drawn from live administrative databases and may subsequently be amended. Due care is taken during processing and analysis, but the detail is subject to inaccuracies inherent in any large scale recording system.</em></p> answering member constituency South West Bedfordshire answering member printed Andrew Selous question first answered 03/11/2014 11:21:01 question first ministerially corrected 03/11/2014 17:23:08 answering member 1453 label Biography information for Andrew Selous previous answer version 25520 answering member constituency South West Bedfordshire answering member printed Andrew Selous answering member 1453 label Biography information for Andrew Selous
	tabling member	1577 label Biography information for Sadiq Khan

101493

	registered interest
	date	28/10/2014
	answering body	Ministry of Justice
	answering dept id	54
	answering dept short name	Justice
	answering dept sort name	Justice
	hansard heading	Prisons: Locks and Keys
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Justice, how many incidents of lost keys there have been in prisons in each year since May 2010.
	tabling member constituency	Tooting
	tabling member printed	Sadiq Khan
	uin	212349
	answer	answer is ministerial correction date of answer 03/11/2014 answer text <p>Security is paramount within prisons and it is important that the risk of any potential key compromise is addressed as quickly as possible in order to protect the public. When a key/lock incident is reported an immediate investigation is undertaken to assess the risk and unless it is clear that security has not been compromised, then locking mechanisms and keys will be replaced and/or other necessary remedial action will be taken.</p><p> </p><p>A range of procedural and physical measures are used to assist in the secure management of keys in prisons. These increasingly include electronic and biometric systems.</p><p> </p><p>The information requested is provided below.</p><p> </p><p>Table 1 - costs of partial/full relocking of prisons due to loss of keys from May 2010 - 29 October 2014:</p><p> </p><p>14/05/2010 Swaleside £95,430</p><p>21/06/2010 Glen Parva £208,329</p><p>04/11/2010 Warren Hill £101,301</p><p>20/12/2010 Ashwell £15,576</p><p>24/10/2011 Birmingham £499,000 <ins class="ministerial">(Paid for by G4S)</ins></p><p>09/01/2012 Maidstone £5,847</p><p>28/02/2014 Lindholme £40,286</p><p>08/05/2014 Haverigg £32,882</p><p>21/07/2014 Highpoint £14, 933</p><p> </p><p>Table 2 – number of reported incidents of lost keys from April 2010 – 31 March 2014:</p><p> </p><p>2010/11 - 62</p><p>2011/12 - 67</p><p>2012/13 – 73</p><p>2013/14 – 35 (* see note below)</p><p> </p><p>* Note: a change in the reporting requirements for key/lock incidents from April 2013 has resulted in a lower “lost keys” figure for 2013/14 in comparison to the three previous years. In addition to keys “lost”, the figures for the three previous years include keys inadvertently taken out of prisons and subsequently returned, but the figure for 2013/14 includes only keys lost, not those inadvertently taken out and returned.</p><p> </p><p><em>The figures quoted have been drawn from live administrative databases and may subsequently be amended. Due care is taken during processing and analysis, but the detail is subject to inaccuracies inherent in any large scale recording system.</em></p> answering member constituency South West Bedfordshire answering member printed Andrew Selous question first answered 03/11/2014 11:21:01 question first ministerially corrected 03/11/2014 17:29:21 answering member 1453 label Biography information for Andrew Selous previous answer version 25521 answering member constituency South West Bedfordshire answering member printed Andrew Selous answering member 1453 label Biography information for Andrew Selous
	tabling member	1577 label Biography information for Sadiq Khan

100630

	registered interest
	date	23/10/2014
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Railways: North West
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the case for improving inter-regional rail links in the North West of England, particularly between East Lancashire and Greater Manchester.
	tabling member printed	Baroness Massey of Darwen
	uin	HL2361
	answer	answer is ministerial correction date of answer 30/10/2014 answer text <p>The case for improving inter-regional rail links in the North West of England has been assessed in a number of studies including the Northern Hub and Network Rail’s Lancashire and Cumbria and North-West Route Utilisation strategies. The case will be further addressed in respect of Network Rail’s Control Period 6 (2019-20<ins class="ministerial">2</ins><del class="ministerial">1</del>4) and beyond through the Northern Route Study as part of Network Rail’s Long Term Planning Process to inform decisions on the Government’s Rail Investment Strategy for Control Period 6.</p> answering member printed Baroness Kramer question first answered 30/10/2014 12:12:57 question first ministerially corrected 05/11/2014 12:17:05 answering member 1557 label Biography information for Baroness Kramer previous answer version 25208 answering member printed Baroness Kramer answering member 1557 label Biography information for Baroness Kramer
	tabling member	2489 label Biography information for Baroness Massey of Darwen

101535

	registered interest
	date	29/10/2014
	answering body	Department for Communities and Local Government
	answering dept id	7
	answering dept short name	Communities and Local Government
	answering dept sort name	Communities and Local Government
	hansard heading	Lighting
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Communities and Local Government, what guidance his Department has issued to local authorities on the level of street lighting they should have in place.
	tabling member constituency	Bury St Edmunds
	tabling member printed	Mr David Ruffley
	uin	212384
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p><ins class="ministerial">Street lighting plays an important role in road safety, as well as ensuring the personal safety of pedestrians. I refer my Hon Friend to the answer of 13 May 2014, Official Report, columns 535-36W, which provides a comprehensive answer on how there is no prescriptive Whitehall guidance, and places in context the policy of the last Administration which actively encouraged cuts to street lighting.</ins></p><p> </p><p> </p><p><del class="ministerial">Street lighting plays an important role in road safety, as well as ensuring the personal safety of pedestrians. There may be some roads where lights could be dimmed in the very early hours, saving taxpayers’ money. However, this should be a local decision by elected local councillors, reflecting local circumstances-specially in relation to any concerns about crime. Equally, not every neighbourhood wants street lighting, as some communities, especially in rural areas, value dark skies.</del></p><p><del class="ministerial">We believe that councils should listen to the views of their local residents, and then adopt appropriate local policies based on the neighbourhood, the precise location and the usage of the road/street. I previously noted that “Manual for Streets” contains some useful guidance on getting the balance right when providing street lighting, taking into account the different issues around safety, crime prevention, street clutter and light pollution. Ultimately, there is no prescriptive Whitehall guidance, and any assessment will depend on local circumstances and local views.</del></p><p><del class="ministerial">Notwithstanding, I would observe that Her Majesty’s Opposition seem to have a short memory about their actions on cutting street lighting when they were in office:</del></p><p><del class="ministerial"><em>Department for Environment, Food and Rural Affairs</em><em>:</em></del></p><p><del class="ministerial">The right hon. Member for Leeds Central (Hilary Benn) (now Shadow Secretary of State for Communities and Local Government) when Secretary of State for Environment, Food and Rural Affairs, his Department and its quangos lectured local councils to switch off or reduce street lighting to minimise carbon emissions. For example, in 2007, he personally launched the Carbon Trust Standard, which was tied to an extensive programme to reduce street lighting as part of the Local Authority Carbon Management Programme. As DEFRA Ministers told the House:</del></p><p><del class="ministerial">“All authorities should be seeking to reduce energy usage both to cut costs and to help combat climate change. As street lighting accounts for a significant proportion of the energy used by authorities, it should be readily identified as an area that should be examined for potential efficiency savings”</del></p><p><del class="ministerial">(6 November 2006, <em>Official Report</em>, column 709W).</del></p><p><del class="ministerial"><em>Department for Transport</em><em>:</em></del></p><p><del class="ministerial">The Minister of State for Transport, the noble Lord Adonis (now a Shadow Treasury Minister) when asked about reducing the hours of operation of street lighting, noted that</del></p><p><del class="ministerial">“the Government also support the Carbon Trust’s local authority carbon management programme, which provides councils with support and guidance to help them realise carbon emissions savings from street lighting”</del></p><p><del class="ministerial">(17 December 2008, <em>Official Report</em>, <em>House of Lords</em>, column WA52). Transport Ministers also endorsed the Highways Agency’s</del></p><p><del class="ministerial">‘Efficiency Strategy for Road Lighting’ which led to switching off motorway lighting at night (21 April 2008,</del></p><p><br /><del class="ministerial"><em>Official Report, </em>column 1444W; Highways Agency</del></p><p><del class="ministerial">“Efficiency Strategy for Road Lighting Midnight Switch Off for Motorway Lighting”, 2009).</del></p><p><del class="ministerial"><em>Department for Communities and Local Government</em><em>:</em></del></p><p><del class="ministerial">The right hon. Member for Normanton, Pontefract and Castleford (Yvette Cooper) (now Shadow Home Secretary), when as Minister in the precursor Department to DCLG, noted there was nuanced debate on the extent of street lighting:</del></p><p><del class="ministerial">“We all recognise the fact that there is a series of tensions around light pollution. People in the cities will never have the same view of the night sky as one can get in the middle of Dartmoor... There can be tensions too at neighbourhood level between the security-obsessed householder who has glaring white security lights stuck to every corner of the house, which flicker on every time a little bird flies past or the cat runs across the garden, and the neighbour who... has a telescope and cannot see across the garden, let alone into the skies”</del></p><p><del class="ministerial">(12 February 2004, <em>Official Report</em>, column 510WH).</del></p><p><del class="ministerial"><em>Department </em><em>of</em><em> Energy and Climate Change</em><em>:</em></del></p><p><del class="ministerial">In 2008, the right hon. Member for Leeds East (Hilary Benn) also personally launched the Carbon Reduction Commitment, which resulted in councils cutting carbon emissions from street lighting, including dimming or switching off lights. The Highway Agency’s “Energy Strategy for Roadside Equipment” (April 2010) explained that the approach of “dimming, trimming and partial night lighting” was a consequence of the requirements to meet the Carbon Reduction Commitment. As DECC Ministers said to the House:</del></p><p><del class="ministerial">“DECC is working to include street lighting in the Carbon Reduction Commitment. This will provide an incentive for local authorities to improve the energy efficiency of street lights. DECC is working closely with Communities and Local Government to develop the policy, in so far as it relates to local authorities”</del></p><p><del class="ministerial">(19 June 2009, <em>Official Report</em>, column 515W). Of course, the Secretary of State for Energy and Climate Change at that time was the right hon. Member for Doncaster North (Edward Miliband) now Leader of HM Opposition.</del></p><p><del class="ministerial">I hope this illuminates the historical fogginess of the Labour party’s current campaign on municipal street lighting. I would suggest the last person out of Labour HQ tonight should turn off the lights.</del></p><p> </p> answering member constituency Keighley answering member printed Kris Hopkins question first answered 06/11/2014 17:31:07 question first ministerially corrected 10/11/2014 17:19:10 answering member 4043 label Biography information for Kris Hopkins previous answer version 26617 answering member constituency Keighley answering member printed Kris Hopkins answering member 4043 label Biography information for Kris Hopkins
	tabling member	133 label Biography information for Mr David Ruffley

105978

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many Instant Rewards of what value were given to his Department's officials in (a) 2013 and (b) 2014 to date.
	tabling member constituency	Barrow and Furness
	tabling member printed	John Woodcock
	uin	213068
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p><del class="ministerial">The Civil Service Commission publish details of appointments made by exception and approved by them in their annual reports and on their website. These reports are available in the Library.</del></p><p><br /><del class="ministerial">It would not be appropriate to publish details of the requests turned down by the Commission as the numbers involved are small, and the individuals might be personally identified, directly or in combination with other published information.</del></p><p> </p><p><ins class="ministerial">The Department does not operate an ‘Instant Rewards’ scheme. The Department does, however, operate an in-year bonus scheme, which has strict criteria, approval processes and budgetary control.</ins></p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 10/11/2014 16:58:06 question first ministerially corrected 10/11/2014 17:38:55 answering member 3932 label Biography information for Dr Dan Poulter previous answer version 27280 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	3917 label Biography information for Lord Walney

100887

	registered interest
	date	24/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Asthma
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much public funding was allocated to research into asthma in each of the last five years.
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	uin	211918
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:28 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	4026 label Biography information for Liz Kendall

100885

	registered interest
	date	24/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Asthma: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much the Government has spent on the development of new drugs to treat the symptoms of asthma in each of the last five years.
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	uin	211885
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:29 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	4026 label Biography information for Liz Kendall

100730

	registered interest
	date	23/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Osteoporosis: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to treat symptoms of osteoporosis in each of the last five years.
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	uin	211735
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:28 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	4026 label Biography information for Liz Kendall